ALGS — Aligos Therapeutics Share News
0.000.00%
Last trade - 00:00- $29.85m
- -$0.47m
- $2.19m
Aligos Therapeutics Inc expected to post a loss of $2.36 a share - Earnings Preview
Aligos Therapeutics Inc expected to post a loss of $2.36 a share - Earnings Preview
Brief: Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule
Aligos Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Aligos Therapeutics Inc expected to post a loss of $2.80 a share - Earnings Preview
Brief: Aligos Therapeutics Inc Files For Offering Of Up To 6.2 Million Common Shares By The Selling Securityholders - SEC Filing
U.S. STOCKS ON THE MOVE-Veren, CME Group, Cognizant
Aligos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Aligos Therapeutics falls on bigger Q4 loss
Brief: Aligos Therapeutics reports fourth-quarter and full-year 2024 results
Aligos Therapeutics Inc expected to post a loss of $2.50 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Chefs' Warehouse, Aptose Biosciences, Electromed
U.S. STOCKS ON THE MOVE-PPG Industries, CME Group, WiSA Technologies
U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Intel, Lithia Motors
Aligos Therapeutics rises after $105 million private placement
Aligos Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Aligos Therapeutics files for mixed shelf of up to $400 mln
Aligos Therapeutics Inc expected to post a loss of $2.16 a share - Earnings Preview
Aligos Therapeutics Inc expected to post a loss of $2.16 a share - Earnings Preview